AMREP CORP (AXR) Fundamental Analysis & Valuation

NYSE:AXR • US0321591051

Current stock price

25.9 USD
-1.04 (-3.86%)
At close:
25.95 USD
+0.05 (+0.19%)
After Hours:

This AXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. AXR Profitability Analysis

1.1 Basic Checks

  • AXR had positive earnings in the past year.
  • In the past year AXR had a positive cash flow from operations.
  • AXR had positive earnings in each of the past 5 years.
  • In the past 5 years AXR always reported a positive cash flow from operatings.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • The Return On Assets of AXR (8.98%) is better than 96.83% of its industry peers.
  • AXR has a Return On Equity of 9.28%. This is amongst the best in the industry. AXR outperforms 84.13% of its industry peers.
  • AXR's Return On Invested Capital of 8.52% is amongst the best of the industry. AXR outperforms 95.24% of its industry peers.
  • AXR had an Average Return On Invested Capital over the past 3 years of 7.98%. This is above the industry average of 5.74%.
  • The last Return On Invested Capital (8.52%) for AXR is above the 3 year average (7.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROIC 8.52%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Profit Margin of AXR (24.40%) is better than 88.89% of its industry peers.
  • In the last couple of years the Profit Margin of AXR has declined.
  • The Operating Margin of AXR (26.06%) is better than 92.06% of its industry peers.
  • In the last couple of years the Operating Margin of AXR has declined.
  • With a decent Gross Margin value of 42.44%, AXR is doing good in the industry, outperforming 69.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AXR has grown nicely.
Industry RankSector Rank
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AXR Health Analysis

2.1 Basic Checks

  • AXR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for AXR has been increased compared to 1 year ago.
  • The number of shares outstanding for AXR has been reduced compared to 5 years ago.
  • AXR has a better debt/assets ratio than last year.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 21.44 indicates that AXR is not in any danger for bankruptcy at the moment.
  • AXR has a Altman-Z score of 21.44. This is amongst the best in the industry. AXR outperforms 96.83% of its industry peers.
  • AXR has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • AXR has a better Debt to FCF ratio (0.00) than 92.06% of its industry peers.
  • AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.00, AXR belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.44
ROIC/WACC0.94
WACC9.08%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • AXR has a Current Ratio of 25.70. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • AXR has a better Current ratio (25.70) than 98.41% of its industry peers.
  • AXR has a Quick Ratio of 11.00. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 11.00, AXR belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 25.7
Quick Ratio 11
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AXR Growth Analysis

3.1 Past

  • AXR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.33%.
  • The Earnings Per Share has been growing slightly by 2.33% on average over the past years.
  • Looking at the last year, AXR shows a decrease in Revenue. The Revenue has decreased by -8.70% in the last year.
  • Measured over the past years, AXR shows a very strong growth in Revenue. The Revenue has been growing by 21.46% on average per year.
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.71% on average over the next years.
  • Based on estimates for the next years, AXR will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. AXR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.75, the valuation of AXR can be described as reasonable.
  • Based on the Price/Earnings ratio, AXR is valued cheaper than 84.13% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of AXR to the average of the S&P500 Index (24.88), we can say AXR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 12.27, AXR is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 93.65% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. AXR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.75
Fwd PE 12.27
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • AXR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AXR is cheaper than 96.83% of the companies in the same industry.
  • AXR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AXR is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.49
EV/EBITDA 6.6
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The excellent profitability rating of AXR may justify a higher PE ratio.
  • A cheap valuation may be justified as AXR's earnings are expected to decrease with -2.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXR Dividend Analysis

5.1 Amount

  • No dividends for AXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXR Fundamentals: All Metrics, Ratios and Statistics

AMREP CORP

NYSE:AXR (3/27/2026, 8:04:00 PM)

After market: 25.95 +0.05 (+0.19%)

25.9

-1.04 (-3.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-12
Earnings (Next)07-23
Inst Owners44.69%
Inst Owner Change-0.97%
Ins Owners45.64%
Ins Owner Change2.08%
Market Cap137.53M
Revenue(TTM)53.00M
Net Income(TTM)12.93M
Analysts80
Price Target23.46 (-9.42%)
Short Float %0.81%
Short Ratio5.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.87%
Min EPS beat(2)-50.49%
Max EPS beat(2)0.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.5%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)2.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)19.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 10.75
Fwd PE 12.27
P/S 2.59
P/FCF 10.49
P/OCF 10.08
P/B 0.99
P/tB 0.99
EV/EBITDA 6.6
EPS(TTM)2.41
EY9.31%
EPS(NY)2.11
Fwd EY8.15%
FCF(TTM)2.47
FCFY9.53%
OCF(TTM)2.57
OCFY9.92%
SpS9.98
BVpS26.25
TBVpS26.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.73
Profitability
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROCE 9.91%
ROIC 8.52%
ROICexc 13.29%
ROICexgc 13.34%
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
FCFM 24.74%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 179.26%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 96.71%
Profit Quality 101.38%
Current Ratio 25.7
Quick Ratio 11
Altman-Z 21.44
F-Score5
WACC9.08%
ROIC/WACC0.94
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y4.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y20.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y22.02%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR Fundamental Analysis FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status of AMREP CORP (AXR) stock?

ChartMill assigns a valuation rating of 7 / 10 to AMREP CORP (AXR). This can be considered as Undervalued.


How profitable is AMREP CORP (AXR) stock?

AMREP CORP (AXR) has a profitability rating of 8 / 10.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.